|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| An evaluation of the use of the transdermal contraceptive patch in |
| Rubinstein ML; Halpern-Felsher BL; Irwin CE Jr |
| Journal of Adolescent Health. 2004 May;34(5):395-401. |
| The purpose was to evaluate the acceptability and feasibility of using the new transdermal contraceptive patch in |
| adolescents. A 3-month longitudinal trial using the Ortho Evra transdermal contraceptive patch in 50 adolescent |
| girls. All healthy girls aged 15-18 years were invited to participate from two San Francisco Bay Area teen clinics. |
| Participants were followed after 1 month and 3 months of treatment. Data were collected on patch detachments, |
| perceived advantages and disadvantages, side effects, and compliance. Data were analyzed using Student's t-test |
| (SPSS). Forty participants (80%) completed 1 month of treatment and 31 (62%) completed all 3 months of the study. |
| There were no pregnancies during treatment. At the 3-month follow-up, 87.1% of participants reported perfect |
| compliance. Ease of use, the fact that it does not require daily attention, and the ease of concealment were among |
| the main reported advantages. Roughly 77% of participants who completed the study were planning to continue using |
| the patch. The 35.5% rate of complete or partial detachment of at least one patch was considerably higher than |
| reported in previous studies of adults. As in adults, the most commonly reported complaints were application site |
| reactions and breast discomfort. This evaluation found an overall positive impression of the new transdermal |
| contraceptive patch, with good rates of short-term compliance and few side effects among adolescents. However, the |
| high degree of detachment unique to this sample of adolescents is concerning and requires further evaluation. |
| (PubHealth.info Document ID: CONT1T 552-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "An evaluation of the use of the transdermal contraceptive |
| patch in adolescents.", is(are) Rubinstein ML; Halpern-Felsher BL; Irwin CE Jr. The source of this article is |
| "Journal of Adolescent Health. 2004 May;34(5):395-401.". This article was published in 2004 in English language(s). |
| (PubHealth.info® Document ID: CONT1T 552-06. All rights reserved with PubHealth.info) PIN: 552 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
